Pharmacokinetic basis for dosing high-dose methotrexate in infants and young children with malignant brain tumours

Pharmacokinetic basis for dosing high-dose methotrexate in infants and young children with malignant brain tumours

Publication: Br J Clin Pharmacol

No population pharmacokinetic studies of high‐dose methotrexate (HDMTX) have been conducted in infants with brain tumours, which are a vulnerable population.

Prediction of pKa Using Machine Learning Methods with Rooted Topological Torsion Fingerprints: Application to Aliphatic Amines

Prediction of pKa Using Machine Learning Methods with Rooted Topological Torsion Fingerprints: Application to Aliphatic Amines

Publication: J Chem Inf Model
Software: ADMET Predictor®

The acid–base dissociation constant, pKa, is a key parameter to define the ionization state of a compound and directly affects its biopharmaceutical profile.

Virtual Patient Generation Strategies for Non-Alcoholic Fatty Liver Disease

Virtual Patient Generation Strategies for Non-Alcoholic Fatty Liver Disease

Conference: ACoP
Software: NAFLDsym®

Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are of growing concern within developed countries, with recent estimates suggesting up to 30% of the US population may be affected.

Combinatorial Designing of Novel Lead Molecules Towards the Putative Drug Targets of Extreme Drug-Resistant Mycobacterium tuberculosis: A Future Insight for Molecular Medicine

Combinatorial Designing of Novel Lead Molecules Towards the Putative Drug Targets of Extreme Drug-Resistant Mycobacterium tuberculosis: A Future Insight for Molecular Medicine

Publication: Essentials of Bioinformatics
Software: ADMET Predictor®

Mycobacterium tuberculosis (Mtb) is one of the notorious pathogens which has led to high mortality rates and demonstrated extreme drug resistance (XDR) to most of the conventional drugs and become a potential threat to public health worldwide.